TURKISH JOURNAL OF PEDIATRICS, cilt.62, sa.5, ss.778-786, 2020 (SCI-Expanded)
Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE. The aim of this study was to determine the risk factors of carbapenem and colistin-resistant Enterobacteriaceae infections and to investigate the outcomes.